HedgeChatter

  • Home /
  • Tag Archives

NVAX

Five Star Biotech Stock Watch: Novavax | Benzinga

It isn’t a surprise to most that the biotech names have had a rough start to the year.
Really, March was pretty bad.
However, with the market recovering as of late, many of the beaten up biotech stocks have rebounded somewhat. A lot of analysts believe the rebound will continue.
As an investor, if you agree with those analysts, then it certainly wouldn’t […]

May 28, 2014 ByChristian Tharp , , , , , , , , , , , Comments Off on Five Star Biotech Stock Watch: Novavax | Benzinga read more

One Year Follow-Up From RSV F-Protein Vaccine Candidate Phase 1 Elderly Trial Demonstrates Sustained Levels of Immune Response

[GlobeNewswire] – GAITHERSBURG, Md. — Novavax, Inc. today announced follow-up data from its dose-ranging Phase 1 clinical trial of its respiratory syncytial virus (RSV) F-protein vaccine in 220 elderly adults (60 years … moreView todays social media effects on NVAXView the latest stocks trending across Twitter. Click to view dashboardSee who Novavax is hiring next, click here to view […]

May 12, 2014 Bystocknews , Comments Off on One Year Follow-Up From RSV F-Protein Vaccine Candidate Phase 1 Elderly Trial Demonstrates Sustained Levels of Immune Response read more

Novavax’s (NVAX) CEO Stanley Erck on Q1 2014 Results – Earnings Call Transcript

[at Seeking Alpha] – Stanley C. Erck Thanks, Buck, and good afternoon, everyone. We’re now 4 months into 2014, and I’m very pleased to tell you that we’ve already achieved a number of our key corporate objectives for this … moreView todays social media effects on NVAXView the latest stocks trending across Twitter. Click to view dashboardSee who Novavax is […]

May 8, 2014 Bystocknews , Comments Off on Novavax’s (NVAX) CEO Stanley Erck on Q1 2014 Results – Earnings Call Transcript read more

Novavax Reports First-Quarter 2014 Financial Results

[GlobeNewswire] – GAITHERSBURG, Md. — Novavax, Inc. , a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, today reported … moreView todays social media effects on NVAXView the latest stocks trending across Twitter. Click to view dashboardSee who Novavax is hiring next, click here to view […]

May 7, 2014 Bystocknews , Comments Off on Novavax Reports First-Quarter 2014 Financial Results read more

Novavax Appoints Sven Andreasson as Senior Vice President, Corporate Development

[GlobeNewswire] – GAITHERSBURG, Md. — Novavax, Inc. , a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, today announced … moreView todays social media effects on NVAXView the latest stocks trending across Twitter. Click to view dashboardSee who Novavax is hiring next, click here to view […]

May 6, 2014 Bystocknews , Comments Off on Novavax Appoints Sven Andreasson as Senior Vice President, Corporate Development read more